Compugen CGEN
NASDAQ CGEN
$2.35 +0.02 (+0.86%)
At close: Sep 29, 2026 · 4:00 PM EDT

Compugen (CGEN) EBITDA Margin (2009 - 2010)

Updated

Compugen (CGEN) reported EBITDA Margin of 43.70% for FY2025, up 95.40 percentage points from -51.70% in FY2024.

Analysis

Compugen (CGEN) EBITDA Margin (2009 - 2010) Analysis & Trends

Dating back to FY2009, Compugen's EBITDA Margin record includes 14 years.

  • EBITDA Margin has a five-year change of +1582.75 percentage points (FY2020 to FY2025).
  • The FY2025 figure ranks as the highest annual EBITDA Margin in data going back to FY2009.
  • According to Business Quant data, EBITDA Margin came in at -51.70% in FY2024 (-14.29 pp), -37.41% in FY2023 (+427.82 pp), -465.23% in FY2022 (+111.66 pp) and -576.88% in FY2021 (+962.17 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Compugen 220.31 Mn -152.78 Mn -92,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 -1,184.21%
Dec 31, 2009 -7,756.00%
API Access

Compugen EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CGEN&period=max&api_key=YOUR_API_KEY